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Summary 
Early in ontogeny thymocytes have a surface marker phenotype that resembles activated mature 
T cells but they lack expression of the T cell receptor (TCR) complex. We have made prepara- 
tions of day 14/15 triple negative fetal thymocytes that exhibit the activated T lymphocyte markers 
CD25, intercdlular adhesion molecule 1, Ly-6A/E, CD44, and heat stable antigen and are rap- 
idly proliferating as evidenced by flow cytometric examination of BrdU incorporation. We found 
that binding activities of the gene regulators nuclear factor (NF)-gB, the NF-gB p50 homodimer 
complex,  nuclear factor of activated T cells (NF-AT), oct-l, oct-2,  activator protein 1 (AP-1), 
and serum response factor (SRF), are all present in these early thymocytes. Whereas the octamer 
factors and SRF persist during ontogeny, NF-gB, NF-AT, and AP-1 decrease and are undetectable 
in the adult thymus. Transfection of disaggregated thymocytes by dectroporation or intact thymic 
lobes by gold-particle bombardment revealed that reporter constructs for NF-gB, NF-AT, AP-1, 
octamer factors and, to a small extent, the TCR-ot enhancer were active in early thymocyte devel- 
opment. We rigorously diminated the possibility  that these transcriptional  events were due to 
minor populations of TCR + cells by showing that these reporter constructs were also active 
in recombinase activating  gene (RAG) -/.  thymocytes that are incapable of completing TCR 
gene rearrangement, and predominantly contain cells that have an activated phenotype. Thus, 
transcriptional  events that are usually triggered by antigen stimulation in mature T  cells take 
place early in thymic ontogeny in the absence of the TCR.  Our analysis suggests  that there 
are striking regulatory similarities but also important differences between the activation processes 
that take place in antigen-stimulated mature T  cells and thymic progenitor cells. 
D 
uring thymic ontogeny, fetal liver derived pre-thymocytes 
undergo a complex process of differentiation  and ex- 
pansion (1). The commitment to the T lineage and some of 
the expansion in cell number occurs before TCR rearrange- 
ment and in cells that lack the surface expression of CD3, 
CD4,  and CD8  (triple  negative,  TN) 1 (2).  Because TN 
thymocytes have not yet rearranged their TCR genes and lack 
expression of the TCR-CD3 complex, they are incapable of 
an activation response through the TCR (3). Thymocyte de- 
velopment follows a stage- and time-specific set of matura- 
tional events. Around gestational  day 12, the murine fetal 
thymus is seeded by hematopoietic precursors from the fetal 
liver. Days 13-15 thymocytes are predominantly TN. TCR 
1 Abbreviations used in thisfmper: AP-1, activator protein-I; CAT, chloram- 
phenicol acetyltransferase; EMSA, electmphoretic mobility shift assay; NF- 
AT, nuclear factor of activated T cells; RAG, recombinase activating gene; 
SRF, serum response factor; tk, thymidine  kinase; TN, triple negative. 
rearrangement and expression of CD4 and CD8 begin by 
days 16 and 17. At a later time in ontogeny (days 18 and 
19), thymocytes expressing antigen receptor, CD4 and CD8 
undergo TCR-mediated positive and negative selection, and 
emerge as self-restricted, self-tolerant, and functional T cells 
(4). Despite the lack of TCK, TN cells exhibit several char- 
acteristics that resemble activated mature TCK + T cells: (a) 
increased cell volume; (b) brisk cellular expansion; (c) expres- 
sion of activated T cell surface markers, such as lymphokine 
receptors and adhesion molecules; and (d) production of sev- 
eral lymphokines (5, 6). For example, TN thymocytes at days 
14 and 15 of fetal development have been shown to express 
mRNA for Iblj3, IL4, II.-5, IL-6, II.-7, IFN-3,,  and TNF 
(7-9). Also expressed are the cell surface molecules: Thy-1, 
CD2, CD16, CD44, heat stable antigen (HSA), thymic shared 
antigen (TSA-1), CD18  (LFA-1), CD54  (ICAM-1),  Ly-6, 
CD26 (THAM-1) and the cx chain of the II.-2 receptor (CD25) 
(10-17). Markers such as CD25, ICAM-1, CD44, and Ly-6 
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tivation (15,  18,  19).  Thus, some aspects  of the activation 
program that are triggered in mature T  cells by TCR en- 
gagement are found in T  cell progenitors in the absence of 
TCR signaling. 
This report addresses  the regulatory molecules that may 
mediate this TCR-independent, activation-like process in im- 
mature TN thymocytes. Recently, other groups have reported 
initial analyses of DNA-binding proteins in different thymic 
subsets (20, 21). Our analysis has concentrated on the func- 
tional and binding properties of elements that may control 
the expression of IL-2 and the ot chain of the IL-2 receptor 
in TN thymocytes. In mature T  ceils the elements control- 
ling these genes have been well established (for a review see 
reference 22).  Our results suggest that although the same 
gene regulatory factors appear to be responsible for the "acti- 
vated" phenotype in both immature and mature T  cells,  a 
TCR-independent pathway leads  to the induction of gene 
regulatory factors early in T  cell development. 
Materials  and Methods 
Mice.  Timed pregnant and 6-wk-old C57B1/6 female  mice were 
obtained from the National Cancer Institute Frederick Research 
Facility. Recombinase activating gene (RAG) 2-/-  mice were ob- 
tained from breeding stocks at the Howard Hughes Medical Insti- 
tute, Children's Hospital (Boston, MA), and bred in National In- 
stitutes  of Health (NIH) animal facilities (23). 
Fetal Thymus Organ Culture (FTOC).  Intact fetal thymic lobes 
were isolated from day 14 embryos and placed in culture as previ- 
ously described (24). Briefly, six individual fetal tbymic lobes were 
placed on the surface of 0.8-/xm Nucleopore filters. Filters were 
supported by a Gelfoam gelatin sponge (20 x  60 x  7 mm). Each 
sponge was placed in a well of a tissue culture dish (6 wells/plate) 
and soaked in 4 ml of  culture medium. The FTOC culture medium 
used was EHAA (Click's) medium supplemented with 10% FCS, 
2 mM glutamine,  10 U/ml penicillin, 100/~g/ml streptomycin, 
100 #g/ml gentamicin, 0.11 mg/ml sodium pyruvate, 5  x  10 -5 
M 2-ME and 10 mM Hepes, pH 7.4. Cultures were incubated at 
37~  in a humidified incubator containing 5% CO2 in air. At the 
end of culture period, the thymus lobes were mechanically  disrupted 
and prepared for flow cytometry analysis or cellular extracts were 
prepared for chloramphenicol acetyltransferase (CAT) assays. 
Flow Cytometry  Cell suspensions were prepared in HBSS (with- 
out phenol red) containing 1% BSA and 0.1% sodium azide (FACS  | 
buffer). Cells (106/100 #1 buffer) were incubated on ice for 30 rain 
with 10 #1 of appropriate antibodies and washed twice before anal- 
ysis. Analysis was performed using a FACScan  |  (Becton Dickinson 
& Co., Mountain View, CA) flow cytometer with the Lysis  II soft- 
ware; data was size and propidium iodide/live gated. All antibodies 
used for flow cytometry were obtained from Pharmingen  (San 
Diego, CA).  For in vivo BrdU labeling, day 15 timed pregnant 
mice were injected intraperitoneally with 2 mg/mouse BrdU in 
PBS. Mice were killed at different times, and fetal thymus cell sus- 
pensions were prepared for flow cytometry analysis as recommended 
by the manufacturer  (Becton Dickinson  & Co.). 
RNA Analysis.  IkNA from freshly isolated fetal thymocytes 
or cultured adult lymph node T cells was isolated using RNAzol-B 
(Tel-Test, Inc., Friendswood, TX) according to the manufacturer's 
instructions, and Northern blot analysis was performed using stan- 
dard procedures (25). 
Nuclear  Extracts  and  Electrophoretic Mobility Shift  Assay 
(EMSA).  Nuclear extracts from freshly isolated fetal thymocytes, 
cultured adult lymph node T cells, or established antigen-specific 
T cell clones were prepared as described previously (26). Protein 
concentrations were determined using an assay  kit (Bio Pad Labora- 
tories, Hercules, CA). EMSAs were performed essentially as de- 
scribed (27), with a custom-designed mini-gel apparatus (Owl 
Scientific, Cambridge,  MA),  using modified conditions. Briefly, 
6-10-#1 reactions were set up in the wells ofa Terasaki  plate (Nunc 
Intermed, Roskilde, Denmark) and contained 2-5-/~g nuclear ex- 
tract protein,  0.5/xg poly[dI:dC],  and 40,000 cpm of 32p-end- 
labeled oligonucleotide probe in a solution of 10 mM Tris-C1, pH 
7.5, 50 mM NaC1, 1 mM dithiothreitol,  1 mM EDTA, and 10% 
glycerol. The samples were incubated at room temperature for 20 
min and loaded with a tapered micropipette tip into the wells of 
the mini-gel apparatus. For competitions, 20-200-fold excess  of  un- 
labeled oligonucleotides were added to the binding mix before the 
addition of the nuclear extract protein. Electrophoresis was carried 
out on 4% Polyacrylamide gels (30:1) in 50 mM Tris, 380 mM 
glycine, 2 mM EDTA, pH 8.5, or 6.7 mM Tris-C1, pH 7.5, 3.3 
mM sodium acetate, and I mM EDTA with buffer recirculation, 
at 11 V/cm for 90 min at room temperature. Gels were dried and 
autoradiographed. Oligonucleotide probes have  been previously de- 
scribed (28). 
In Vitro Transfections.  Cell suspensions were washed and placed 
in RPMI 1640 medium supplemented with 20% FCS. Cells were 
transfected  by electroporation using a B'TX (San Diego, CA) Electro 
Cell Manipulator 600 apparatus with each sample containing 5-10 
x  1@ cells/cuvette (4-mm gap) in 250/~1 medium. Samples were 
incubated on ice for 10 min with 10-15 #g CsC1 purified CAT 
reporter plasmid DNA and were electroporated  at 250 V, 1900/~FD, 
186 ohm, with an ,~100 millisecond  time constant. After electropo- 
ration,  samples were incubated on ice for 10 rain, and then cul- 
tured for 24-36 h in FTOC medium. CAT reporter plasmids used 
in the analysis have been previously described (28, 29). 
In Vivo Transfection.  In vivo transfections  were carried out using 
an  accelerated DNA/particle bombardment  (biolistic) delivery 
system. Intact fetal thymic lobes from FTOC were used as targets 
for DNA-covered gold particles (0.5-2/~m) using modifications 
of the technique previously described (30). After 1 d in culture, 
intact thymic lobes from day 14 mice on nucleopore filters were 
briefly removed from their Gelfoam sponge support and subjected 
to bombardment  by accelerated DNA/gold particles in  a self- 
constructed apparatus as follows: 30/xg of CAT reporter plasmid 
DNA and 1 mg gold (Aldrich Chemical Co., Milwaukee, WI) par- 
ticles were mixed at room temperature  in  a solution  of 1.2 M 
CaCI2 and 100 mM spermidine at a final volume of 30/xl for 20 
rain. The DNA-gold suspension was microcentrifuged, decanted, 
and  resuspended in  70%  ethanol  (wash), microcentrifuged, 
decanted, and resuspended in 100% ethanol. DNA/gold particles 
were spotted onto a mylar film and allowed to air dry. DNA/gold 
particles were accelerated by the force of a 10-12-kV electric dis- 
charge from a 2-/zF capacitor. The discharge apparatus was con- 
tained within a vacuum chamber. The mylar film was positioned 
in between the discharging electrodes and a steel screen (100 mesh) 
(7 mm between the mylar film and the screen), which stopped the 
film but allowed the particles to travel to their target (5 mm dis- 
tance between the screen  and the fetal  thymic lobes). The fetal  thymic 
lobes were coated with DNA/gold particles that penetrated to a 
depth of 8-10 cell layers, as determined by microscopic examina- 
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was apparent, and the fetal lobes remained viable. The entire pro- 
cedure lasted  <1 min and the lobes were  placed  back onto the sponge 
for a 24-48-h culture. 
CATAssays.  CAT assays were performed  using standard  proce- 
dures (31) and extracts were normalized by protein concentration. 
Chloramphenicol  conversion  was quantitated  directly  after thin layer 
chromatographic separation  by using a Fast Scan Computing  Den- 
sitometer (Molecular Dynamics, Inc., Sunnyvale, CA). 
Results and Discussion 
Da~ I4/15 Fetal Thyrnocytes  Have Phenotypic  Features of  Ac- 
tivatedMature T Lymphocytes.  Day 14/15  fetal thymocytes 
were prepared by removing thymic lobes by microscopic sur- 
gery and disrupting the organ structure by gentle homogeni- 
zation. Thymocytes were purified by fine mesh filtration that 
trapped stomal supporting cells. Preparations were >98% free 
of stromal cells as determined by flow cytometry. Such prepa- 
rations yielded fetal thymocytes negative for CD4 and CD8 
(data not shown). Though day 14 double-negative cells may 
contain a very small fraction of T  cells bearing Vy3/V81 
receptors (32), the vast majority are progenitor cells that have 
not yet begun rearrangement of the ce and/3 TCR loci. Scollay 
et al. (5), and other groups have used several markers to sub- 
divide and determine lineages using analytical flow cytometry 
of adult CD4-/CD8-  thymocytes (33).  Flow cytometric 
analysis shows that our preparation of fetal thymocytes ex- 
press cell surface markers that are characteristically  present 
or upregulated on activated mature TCR + T cells including 
CD25 (I1:2P,  o  0 (22), CD54 (ICAM-1) (18), CD59 (Ly-6A/E) 
(15), HSA (Ztt~iga-Pfliicker, J. C., unpublished observations) 
and CD44 (Pgp-1) (19) (Fig. la). The cells are <1% positive 
for CD3 (Fig.  1 a).  These cells are also undergoing rapid 
DNA synthesis as evidenced by the high percentage (>25 %) 
incorporating the nucleoside analog BrdU into their DNA 
within the first 2 h of in vivo exposure (Fig. 1 b). Adult un- 
fractionated thymocytes do not show a high incorporation 
of BrdU in such a short time (<10%; data not shown) (34). 
Early thymocyte resemblance to activated mature T cells is 
also apparent in a Northern blot probed for I1:2 mRNA (Fig. 
2). I1:2 message is present early in ontogeny (day 14), peaked 
by day 15, decreased by day 16, and virtually absent later in 
development when the percentage of immature TN thymo- 
cytes is very low. The apparent transcription of the I1:2 gent 
must be initiated early in thymocyte development since there 
is a high expression by day 14 and no expression in fetal liver. 
Previous studies have provided evidence both for and against 
the notion that the I1:2 produced by fetal thymocytes con- 
tributes to the cellular proliferation that occurs at this early 
stage (6, 35-38).  Nevertheless,  the expression of the many 
lymphokines and their receptors can be interpreted as evi- 
dence of an inductive or activation event. Taken together with 
previous reports, these results indicate that our preparations 
of early TN thymocytes contain cell types that appear to mimic 
the phenotype of activated  mature T  cells. 
Molecular Control  of  Activation in Immature Thymocytes.  The 
functional phenotype and precursor potential of TN thymo- 
cytes implies that highly regulated molecular events lead to 
the pattern of gent expression  observed in these cells. We 
prepared nuclear extracts  from fetal thymocytes at different 
stages of development and analyzed DNA-binding transcrip- 
tion factors by EMSA. We studied the factors implicated in 
the control of I1:2 and I1:2Roe genes, which are expressed 
by mature T cells after TCR-mediated activation (22, 28, 29). 
Fig. 3 a shows that early in development (day 14-16),  nu- 
clear extracts from fetal thymocytes contain the nuclear factor 
(NF)-rd3 (20), which governs many genes with immunoregula- 
tory function (39). The complex can be competed by using 
unlabeled oligonucleotides containing the Ig-NF-KB recog- 
nition sequence (Fig. 3 a,  +,  + +), but not by an irrelevant 
oligonucleotide (Fig. 3 a, n). The NF-KB heterodimer (pS0/ 
p65) participates in the transcription of the I1:2 and I1:2Roe 
genes in antigen-activated mature T cells, but is lower in abun- 
dance in resting T  lymphocytes (28).  Though NF-KB was 
evident in early development (days 14-16), the complex was 
not detected at later times (day 18 to adult) when CD3 + 
cells were predominant. 
Resting mature T cells contain large amounts of a faster 
migrating p50 homodimer  complex, NF-KC, which is down- 
regulated after antigen activation (28). The I1:2KB site can 
be repressed by NF-KC (28). We observed significant quanti- 
ties of the NF-KC complex throughout thymic ontogeny (Fig. 
3 a), suggesting that the IL-2KB site and the 1I:2 gent may 
be modestly active in some early cells and completely shut 
off at later times. These results are consistent with 11:2 mRNA 
(Fig. 1 b), which is present at day 14/15 but then undetected 
from day 17 onward. Moreover, the early presence of significant 
levels of the NF-KC repressor complex may explain previous 
in situ hybridization data showing that many thymocytes even 
at day 14/15 do not express I1:2 mRNA and positive cells 
have significantly fewer 11:2 transcripts than other genes ex- 
pressed at this stage (40; Ztifiiga-Pflticker, J. C., unpublished 
observations)  (see below). Thus, two forms of KB complex 
are present in immature TN thymocytes including the active 
form of the NF-KB complex that upregulates I1:2 and I1: 
2Rol gent expression  in mature T  cells. 
Day 14/15 thymocytes, but not adult thymocytes, also ex- 
press the DNA-binding complex activator protein (AP) 1 (Fig. 
3 b). The AP-1 transcription factor is comprised of the prod- 
ucts of the c-~s and c-jun oncogenes (41), and found to be 
expressed early during the activation of T cells (22). Func- 
tional AP-1 sites are present in the I1:2 gent (29). The pro- 
tein-DNA complex that we detect can be specifically com- 
peted by a consensus AP-1 recognition sequence (Fig.  3 b, 
+,  + +), but an irrelevant oligonucleotide (Fig. 3 b, n) fails 
to compete. We also found that another oncogene product, 
c-myc, that may control cell cycle progression and is induced 
upon activation (22), is present in the early thymocytes (day 
14-15)  (data  not shown). 
Recently, it was shown that the nuclear factor of activated 
T cells, (NF-AT), is comprised of the oncogene products of 
c-Jbs and c-jun and an unidentified novel subunit, creating 
a protein complex that specifically recognizes the NF-AT ele- 
ment (42). The NF-AT complex is an inducible DNA-binding 
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Figure 1.  (a) Two parameter flow cytometry analysis of cell surface molecules expressed on day 15 fetal thymocytes of C57B1/6 mice, CD44 (Pgp-1) 
vs. THY-1, CD25 (IL-2R), HSA, CD54 (ICAM-1), CD59 (Ly-6A/E), and CD3. Freshly isolated fetal thymocyte suspensions were prepared for flow 
cytometry as described in Materials and Methods. Thymocytes were >98% free from stroma elements as determined by forward- vs. side-scatter. (b) 
Freshly isolated day 15 fetal thymocytes from pregnant mice treated intraperitoneally with 2 mg/mouse of BrdU were isolated at the indicated times 
and ftxed with ice-cold ethanol.  Fixed cells were stained with anti-BrdU antibody and propidium iodide. Antibodies used for flow cytometry were 
obtained from Pharmingen (San Diego, CA). All plots display 10,000 events; the events contained in each quadrant  are given as percent of total in 
the upper  right corner. 
1142  Transcription in Immature Thymocytes Figure 2.  Northern  blot analysis  of  RNA from  thymocytes  at different 
stages of development  and lymph node  cells that were  freshly  isolated or 
stimulated for 6 h with 5/~g/ml Con A. The Northern blot was succes- 
sively hybridized  with mouse  II.-2 and actin eDNA  probes. Probes were 
obtained  from  restriction  fragments  of plasmids  containing  the mouse  Ib2 
or mouse  actin  cDNAs. Restriction  fragments  were  labeled  using  a random 
primed  DNA hbeling  kit (Boehringer  Mannheim,  Indianapolis,  IN). Prep- 
aration of lymph node (Rest/Stira)  RNA showed  equal loading and in- 
tegrity  as determined  by ethidium  bromide  staining. (Arrows)  mRNA cor- 
responding to the appropriate molecular  weight. 
complex responsible for IL-2 gene control in activated T cells 
(22).  NF-AT is expressed at low levels by the earliest thymo- 
cytes (day 14), increases to high levels at day 15 and 16, and 
then is undetectable in the adult thymus (Fig. 3 c). The NF-AT 
complex can be specifically competed with the NF-AT rec- 
ognition sequence (data not shown). Thus,  the expression 
of IL-2 mRNA early in development (days 14-16),  but not 
in adult thymus, correlated with the presence of three acti- 
vators of the IL-2 gene: NF-KB, AP-1, and NF-AT. The delayed 
appearance of the NF-AT complex may account for the IL-2 
RNA peaking by day 15 instead of day 14 when NF-~cB and 
AP-1 are highest, moreover NF-AT reaches its maximum level 
by day 16 when NF-KB and AP-1 are decreasing. Thus, day 
15 may constitute the moment when all three factors reach 
sufficient levels for the induction of IL-2, whereas in day 14 
NF-AT is limiting, and in day 16 NF-KB and AP-1 are lim- 
iting. This intricate pattern also suggests that more than one 
activation/induction  event  is  acting  upon  these  early 
thymocytes. 
We also detected the presence of the homeo-domain pro- 
teins oct-1 and oct-2 (43) and the serum response factor (SRF) 
(44)  throughout thymic development (Fig.  3, d and e). In 
adult thymus, oct-2 is present at comparatively low amounts. 
Therefore, our results show the binding activities of certain 
inducible T cell transcription factors,  NF-KB, AP-1, NF-AT, 
and oct-2 that control T  cell activation genes such as IL-2 
or the IL-2 receptor cr  chain gene are largely restricted to 
a  stage  early  in  thymocyte  development.  At  the  later 
CD4+/CD8 +  (double  positive)  stage  of  differentiation, 
which comprises >80%  of adult thymocytes, these factors 
are apparently switched off (45). By contrast, factors that are 
constitutively expressed in mature T  cells such as oct-1 and 
SP,  F are present early on and maintained throughout thymic 
development. 
Functional Presence of Key Regulatory Factors in Immature 
Thymocytes.  We next  sought evidence that  these nuclear 
factors were functional. We transfected several CAT-reporter 
constructs (Fig.  4  and 28,  29)  into  fetal thymocytes. The 
CAT-reporter constructs contained tandem repeats of the rec- 
ognition sequences for the various nuclear factors driving min- 
imal promoters from either the thymidine kinase (tk) or c-j~s 
genes (Fig. 4). Fig. 5 shows that day 14 fetal thymocytes trans- 
fected with a plasmid containing two copies of the Ig-NF-KB 
site display a high level of CAT enzyme activity. The activity 
observed indicates that the NF-KB present in early thymo- 
cyte nuclei can  effectively drive  the expression of a  CAT 
reporter gene. However, the thymocytes in this experiment 
were tested in cell suspension and therefore not in their nat- 
ural thymic micro-environment. 
To preserve the structural integrity of the thymus during 
gene analysis, a novel approach, biolistics, allows for the in- 
troduction of plasmid DNA into intact cells, tissues, or organs, 
using the penetration of accelerated DNA-coated gold micro- 
spheres (30).  We adapted biolistics to study gene expression 
in intact fetal thymic lobes. Initial control experiments showed 
that biolistic DNA transfer did not appreciably disrupt the 
fetal thymic structure, presumably allowing the transfected 
cells  to respond to  the normal environmental stimuli that 
the thymic architecture imparts (46). Histochemical analysis 
showed that DNA/gold particles could effectively  penetrate 
as deep as six to eight cell layers into  the subcapsular and 
outer cortical region of the fetal thymic lobe and could trans- 
fecta wide distribution of immature thymocytes, therefore 
obtaining a representative transfected population (data not 
shown). As with the electroporated day 14 fetal thymocytes 
(Fig. 5), the fetal lobes transfected by biolistics  showed strong 
transcriptional activity of an NF-KB binding element (Fig. 
6). A construct with mutated NF-~cB sites gave no CAT ac- 
tivity by this approach (data not shown). This confirms that 
the presence of active NF-KB  apparent in previous experi- 
ments (Fig.  5) is not an artifact of our cell preparations. Al- 
though the biolistic method provided successful transfections, 
it was less efficient than transfection by electroporation of 
cell suspensions. 
Biolistic transfections also revealed that reporter constructs 
driven by the binding sequences for NF-AT, AP-1, and the 
octamer factors,  as well as the TCR-c~ enhancer (47),  were 
activated above the minimal level of activity of the tk or c-J~s 
minimal promoter alone. The NF-KB and the AP-1 reporter 
constructs consistently gave the strongest signal whereas the 
octamer reporter was the weakest. Control experiments with 
either mock CAT reactions or extract from thymuses bom- 
barded with DNA-free gold particles confirmed that there 
was no nonspecific acetylation of chloramphenicol (Fig.  6). 
Because each of these reporter constructs is activated in ma- 
ture T  cells stimulated by peptide antigen (29),  immature 
thymocytes are capable of transcriptional processes that are 
characteristic of activated mature T  cells.  Consistent  with 
the EMSA results showing an abundance of the inhibitory 
NF-IcC p50 homodimer complex, the IL-2KB motif or the 
entire IL-2 promoter which contains a site with high afffnity 
1143  Zttttiga-Pflficker  et al. Figure 3.  EMSA  of nuclear extracts from thymocytes at different stages of development. Nuclear extracts were prepared from freshly isolated thymo- 
cytes, lymph node cells, or CD4 § T.1 cell clone (AE7) (28, 29) as described in Materials and Methods.  Lymph node cells were stimulated with 5 
#g/ml of Con A for 6 h and A.E7 cells were stimulated with 10 #M peptide antigen presented by APCs (29). The extracts were mixed with 32p. 
oligonucleotide  probe containing binding sequences as previously described (29) for the (a) NF-KB, (b) AP-1, (c) NF-AT, (d) SRF, and (e) octamer. 
(a and b) Day 14 FT nuclear extracts were treated as above (-), or with the addition of a cold oligonucleotide probe competitor,  either specific (+, 
+ +) (4 or 8 ng, respectively) or nonspecific (n, 8 ng). Note that the AP-1 autoradiograph  is overexposed so that the difference between day 15 and 
adult is clear though induction in the lymph node is obscured. The NF-KB oligo contains the NF-KB consensus site from the mouse Ig K light chain 
enhancer;  the AP-1 oligo contains the AP-1 consensus site from the human collagenase enhancer; the NF-AT oligo contains the NF-AT consensus 
site from the mouse 11,2 enhancer; the SRF oligo contains the consensus SRF site from the human II~2Kc~  enhancer; and the octamer oligo contains 
the consensus octamer  site from the mouse I1,2 enhancer. 
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for the p50 complex yielded low activity in a biolistics assay 
(data not shown). These results reinforce the notion that IL-2 
is synthesized at low levels by a fraction of early thymocytes. 
Because most day 14 thymocytes  lack a TCR-CD3 complex, 
the transcriptional events we observe  may be governed by 
a novel and distinct pathway of activation. 
Functional Expression of Key Enhancer Element Factors in 
RAG2 -/-  Thymocytes.  Although the vast majority of day 
14/15 fetal thymocytes do not bear TCRs, there exists a small 
percentage of either TCR÷-T/~  and TCR+-ol/~/  thymo- 
cytes (1). These TCR + thymocytes may influence the state 
of activation of the other thymocytes, or themselves display 
the gene regulatory molecules of activated  mature T  cells, 
which are detected by our sensitive EMSA and CAT reporter 
transfection assays. To directly address this issue, we used mu- 
tant mice lacking the RAG2 that do not undergo DNA recom- 
OCTA  TK  CAT 
"I'CI~  TK  CAT 
II,'0 
NF-ICB  c-los  CAT 
c-fos  CAT 
Figure  4.  Diagram of the CAT 
reporter plasmid used for transfec- 
tants. The backbone plasmid was ei- 
ther the pBLCAT2 plasmid or the 
A56-c-fis-CAT  plasmid  (28,  29). 
Oligonucleotides  containing  the 
various c/s-acting sequences, as in- 
dicated in the Fig. 3 legend, were 
cloned in front of the TK or c-fos 
minimal promoters,  as monomers 
or in tandem repeats as indicted by 
the number of arrows. The plasmid 
constructs  were previously verified 
by DNA sequencing  (29). 
bination in the  joining regions of antigen receptor genes (23). 
These thymocytes  cannot produce a TCR and remain arrested 
at the TN  stage  of development (23).  Thus, thymuses of 
RAG2 -/-  mice serve as source of TN thymocytes without 
contamination by TCR + ('y/6-a/~)  cells. Fig. 7 a  shows 
that thymocytes prepared from young adult RAG2-/-  mice 
are very similar to day 14/15 fetal thymocytes by flow cytom- 
etry analysis, because they both have high percentages of Thy-1, 
HSA, CD25  (IL-2R),  CD54  (ICAM-1),  and  CD59  (Ly- 
6A/E),  positive cells. They  differ  in  that  the  RAG2 -/- 
thymocytes have relatively fewer CD44 bright cells than day 
14/15  fetal thymocytes. Moreover,  the RAG ./.  thymocyte 
Eleetroporatlon of Day 14 FT 
Figure  5.  NF-~B is function- 
ally active in day 14 fetal thymo- 
cytes.  24 h  after  transfection  by 
electroporation  with the Ig-NF- 
KB-CAT construct  or  the pBb 
CAT2 backbone,  thin layer chro- 
matographic  analysis  of  CAT 
enzyme activity of cellular extracts 
from transfected day 14 fetal thy- 
mocytes  (6  x  106  cell/sample) 
were performed. Mock CAT reac- 
tion was used  on extracts  from 
thymocytes  that  were not  elec- 
troporated.  CAT assays were nor- 
malized for protein content of the 
cellular extract.  25 Izg of protein 
were used in each assay. Percent 
acetylation of 6.0, 6.1, and 61.1% 
were  observed  for  mock,  pBL- 
CAT2,  and  p-lg-NF-~cB-CAT 
transfections,  respectively. 
Figure 6.  Biolistic transfection  demonstrates  the transcriptional  func- 
tions of intact day 14 fetal thymic lobes. FTOC were set up as described 
(23) and served as targets  for the accelerated gold/DNA particles, 48 h 
later  CAT assays of cellular extracts  were performed.  Biolistic transfec- 
tions are detailed in the Materials and Methods  section. Two independent 
experiments (a and b) are shown that are representative of six experiments. 
CAT assays were normalized  for protein content of the cellular extract. 
20 #g of protein were used in each assay. 30-48 fetal lobes were used for 
each bombardment. Induction of CAT activity as determined  by percent 
acetylation over backbone control:  (a) octamer 1.7X, Ig-NF-gB 4.2X, AP1 
5.8X;  (b) NF-AT 2.5X,  AP-1 2.8X,  TCR 1.4X,  Ig-NF-~B 3.6X. 
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Figure  7.  (a) Two parameter flow cytometry analysis of cell surface molecules expressed on thymocytes from RAG2-/- mice, CD44 vs. THY-1, 
CD25 (II~2R), HSA, CD54 (ICAM-1), CD59 (Ly-6A/E), and CD3. Freshly isolated young adult thymocyte suspensions were prepared for flow cytom- 
etry as described. Thymocytes were >98% free from stroma elements as determined by forward- vs. side-scatter. (b) Freshly isolated young adult thymo- 
cytes from mice treated intraperitoneally  with 0.5 mg/mouse of BrdU were collected at the indicated times and fixed with ice-cold ethanol.  Fixed 
cells were stained with an anti-BrdU  antibody and propidium  iodide. All plots display 10,000 events. The events contained in each quadrant  are given 
as percent total (top right comer). 
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tional dements are functionally 
active  in  thymocytes  from 
RAG2-/- mice. After a 24-h in- 
cubation, CAT assays of cellular 
extracts  from  freshly  isolated 
thymocytes  from  4-wk-old 
ILAG2-/-  mice  transfected  by 
dectroporation (10  ￿  106 cells/ 
sample)  were  performed.  CAT 
assays were normalized for protein 
content of the cellular extract. 25 
/~g of protein was used in each 
assay. Shown is a representative  ex- 
periment from two independent 
trials. Average induction  of CAT 
activity as determined by percent 
acetyhtion over backbone control: 
Ig-NF-~B  6.3X,  NF-AT  2.4X, 
AP-1 9.2X, TCR.~ 1.5X. 
population is almost entirely encompassed by the IL-2R + 
stage of thymic development (>90%), allowing us to better 
assess this specific stage in T  cell development. 
Thymocytes from in vivo BrdU treated RAG -/.  mice 
showed a high percentage of cells incorporating the nucleo- 
side analog in a 4-h period (>25%) (Fig. 7 b), similar to that 
seen in fetal thymocytes. Surprisingly, this data suggests that 
RAG2-/-  thymocytes are proliferating despite the fact that 
the thymus is <10% the size of a normal adult mouse (23). 
As  shown in Fig.  8,  electroporation of freshly isolated 
RAC2 -/-  thymocytes  with  NF-KB, AP-1,  NF-AT, and 
TCR-c~ enhancer plasmid CAT reporter constructs reveals 
that, as in the fetal immature thymocytes, each is active. Again, 
the NF-KB and the AP-1 constructs consistently give the 
strongest activity. Thus, the activation-like molecular features 
of fetal thymocytes are apparently not due to the presence 
of small numbers of TCR + thymocytes. These data further 
support the view that the early TN thymocytes may employ 
a novel, TCR-independent, activation pathway which is in- 
tact in the RAG2 -/-  thymocytes. 
Conclusion,  Our data show that day 14/15 TN fetal thymo- 
cytes contain a large population of cells that have the pheno- 
type of antigen-activated mature T  cells. On their surface, 
these cells express IL-2Rc~  chain, HSA, Ly-6A/E, and ICAM-1, 
but have no TCR-CD3 complex. These cells were also prolifer- 
ating and expressed IL2 mRNA. At the molecular level, we 
detected the presence of the DNA-binding transcription factors 
NF-KB,  NF-gC, AP-1, NF-AT, SRF, oct-l,  and low levels 
of oct-2. These binding activities are functional since trans- 
fected CAT reporter constructs dependent on their respec- 
tive c/s elements were active. In adult thymocytes, the NF- 
KB, NF-AT, and AP-1 binding complexes were undetectable, 
and it was not possible to test transfected DNA in these cells 
because they are quiescent (48).  Finally, RAG2 -/-  thymo- 
cytes which were genetically devoid of any TCR + cells, had 
a similar cellular, proliferative,  and molecular phenotype to 
day 14/15  TN thymocytes. In contrast to activated  mature 
T  cells, the IL2 promoter, the octamer element, and the 
TCR-ot enhancer exhibit only weak activity in day 14/15 TN 
fetal thymocytes. Thus, early thymocytes differ from activated 
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mature T  cells in that they have high expression of the IL- 
2Rol gene, but apparently low expression of the IL-2 gene itself. 
Newly arriving thymic progenitors come to thymus and 
encounter a nurturing atmosphere that commits them to a 
path of T cell differentiation. Our results suggest that upon 
commitment to this path, early thymocytes are "stimulated" 
and enter an activation-like state.  The transcription events 
we observed involving NF-KB, AP-1, and NF-AT are prob- 
ably not simply a reflection of the proliferating nature of early 
thymocytes. In mature T  cells, the activity of these trans- 
activators  are induced by specific signaling pathways,  cause 
Ib2 production and proliferation, and then disappear when 
the process is underway (22,  28,  29). 
We envision that the activation state of early thymocytes 
may serve two purposes. First, the primary role of the activa- 
tion state may be to promote cell proliferation to expand the 
pool of potential thymic precursors. DNA replication at this 
stage may facilitate the process of TCR gene rearrangement. 
The fetal thymus grows in size exponentially during gesta- 
tional days 13-17. This can be attributed, in part, to a con- 
stant influx from the fetal liver, but also to a rapid prolifera- 
tion of new arrivals, as shown in this report (Fig. 1 b). Previous 
reports (49) show that thymic precursors  lie within the IL- 
2R + population, indicating that up to this stage in thymic 
development, precursor potential is retained. A second role 
of the activation state may be to indicate successful commit- 
ment to the T  lymphoid lineage by a transient display  of 
differentiated functions. We favor the speculative idea that 
early thymocytes that fail to display the "activated" pheno- 
type would be selected against during ontogeny and may even 
undergo elimination within the thymus. 
Early thymocytes actively express lymphoid-specific induc- 
ible genes that are recapitulated later in the life of the T cell. 
In other instances genes expressed early in development  later 
take on a new or related role in the adult organism (50, 51). 
It is important also to consider that the transcriptional pheno- 
types we detected in TN thymocytes and antigen-activated 
mature cells were not identical.  Many day 14/15 thymocytes 
are strongly IL-2Rc~  + and express significant amounts of ID 
2Rc~ mRNA (data not shown), but IL-2 expression is quite 
low. Moreover, whereas NF-r.B and AP-1 elements were highly 
active,  NF-AT  was  intermediate,  and  the  octamer  motif 
was weakly expressed. Thus, early thymocyte IL-2Rcr + stage 
may reflect a modified subset of the gene activation events 
found in antigen-activated mature T cells. However, because 
day 14 TN thymocytes are likely to contain a variety of sub- 
populations (1-3),  it is difficult  to precisely delineate their 
differences with mature cells. 
The notion  that  immature thymocytes undergo TCR- 
independent activation implies the existence of a signaling 
pathway independent of the  TCR-CD3  complex that  is 
important  for  early  thymic  development.  The  fact  that 
RAG2 -/-  thymocytes show a  similar  pattern  of cellular, 
proliferative,  and transcriptional features also suggests some 
form of TCR-independent activation. The most likely source 
for an activation stimulus is the thymic stroma. However, 
the molecular signals between fetal liver (bone marrow) im- 
migrants and thymic stromal cells that govern the activation process  are as yet obscure.  Recent evidence  indicated that 
thymocyte  differentiation  requires interactions with more than 
one kind of stromal cell (52,  53). 
It is intriguing that RAG2 -/-  thymocytes rapidly incor- 
porate the nudeoside analog BrdU in vivo,  suggesting that 
they are actively proliferating (Fig. 7 b). By our analysis and 
that  of others  (23),  the  thymus in  RAG2 -/-  mice  only 
achieves a size less than one tenth that of a normal mouse. 
Cell counts confirm the smaller organ in RAG -/- mice con- 
tains <10% of the normal number of cells in the adult. This 
is about the same number of TN thymocytes present in a 
normal adult thymus. It is puzzling that the TN thymocytes 
are incapable of occupying the "space" that typically accom- 
modates TCR + cells. Recent evidence suggests that survival 
into the next step of differentiation may be mediated through 
the expression of a rearranged TCR/3 chain homodimer (54). 
The  similarity of the  persisting  phenotype of RAG2 -/- 
thymocytes to that of fetal thymocytes  before TCR rearrange- 
ment would be consistent with a limited thymic lifespan if 
TCR is not available to allow thymocyte differentiation to 
proceed. 
Taken together, our data suggests that immature thymo- 
cytes appear to undergo a process of TCR-independent acti- 
vation that might increase the number of thymocyte  precursors 
as well as stimulate the differentiation process and lymphoid 
lineage commitment. The activation events, when examined 
molecularly, partly resemble those seen in mature antigen- 
activated T  cells. 
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